{"id":5116,"date":"2024-04-17T00:08:03","date_gmt":"2024-04-17T04:08:03","guid":{"rendered":"https:\/\/colpittsclinical.com\/?p=5116"},"modified":"2024-04-21T23:52:52","modified_gmt":"2024-04-22T03:52:52","slug":"supporting-patients-with-fabry-disease-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/colpittsclinical.com\/lt\/supporting-patients-with-fabry-disease-in-clinical-trials\/","title":{"rendered":"Pagalba Fabri liga sergantiems pacientams klinikiniuose tyrimuose"},"content":{"rendered":"<h2 class=\"x_MsoNormal\"><b>Atotr\u016bkio ma\u017einimas: pagalba Fabri liga sergantiems pacientams atliekant klinikinius tyrimus<\/b><\/h2>\n<p class=\"x_MsoNormal\">Balandis - tai m\u0117nuo, skirtas informuotumui apie Fabri lig\u0105 - ret\u0105 genetin\u012f sutrikim\u0105, kuriuo serga t\u016bkstan\u010diai \u017emoni\u0173 visame pasaulyje. \"Colpitts Clinical\" pripa\u017e\u012fstame, kad svarbu remti pacientus, sergan\u010dius tokiomis retomis ligomis kaip Fabri liga, ir u\u017etikrinti, kad jie tur\u0117t\u0173 galimyb\u0119 gauti pa\u017eangiausius gydymo b\u016bdus atliekant klinikinius tyrimus. \u0160iame prane\u0161ime nagrin\u0117sime Fabri ligos \u017einomumo m\u0117nesio svarb\u0105 ir tai, kaip \"Colpitts Clinical\" atlieka svarb\u0173 vaidmen\u012f ma\u017einant atotr\u016bk\u012f tarp pacient\u0173 ir jiems prieinamo gydymo.<\/p>\n<p class=\"x_MsoNormal\"><strong><i>Fabri ligos supratimas:<\/i><\/strong><\/p>\n<p class=\"x_MsoNormal\">Fabri liga yra retas genetinis sutrikimas, kur\u012f sukelia fermento, vadinamo alfa-galaktozidaz\u0117s A (\u03b1-Gal A), tr\u016bkumas. D\u0117l \u0161io fermento tr\u016bkumo \u012fvairiose organizmo l\u0105stel\u0117se kaupiasi tam tikri riebalai, pirmiausia globotriaosilceramidas (Gb3). Laikui b\u0117gant \u0161is kaupimasis gali sukelti \u012fvairi\u0173 simptom\u0173, \u012fskaitant skausm\u0105, inkst\u0173 funkcijos sutrikimus, \u0161irdies komplikacijas ir neurologines problemas. Nepaisant to, kad Fabri liga yra reta, ji gali tur\u0117ti didel\u0119 \u012ftak\u0105 pacient\u0173 gyvenimui, paveikti j\u0173 gyvenimo kokyb\u0119 ir bendr\u0105 sveikat\u0105.<\/p>\n<p class=\"x_MsoNormal\"><strong><i>\"Colpitts Clinical\" vaidmuo:<\/i><\/strong><\/p>\n<p class=\"x_MsoNormal\">\"Colpitts Clinical\" supranta i\u0161\u0161\u016bkius, su kuriais susiduria retomis ligomis sergantys pacientai, \u012fskaitant galimyb\u0119 gauti specializuot\u0105 prie\u017ei\u016br\u0105 ir dalyvauti klinikiniuose tyrimuose. Tod\u0117l esame pasiry\u017e\u0119 ma\u017einti atotr\u016bk\u012f tarp pacient\u0173 ir jiems prieinamo gydymo. M\u016bs\u0173 komanda glaud\u017eiai bendradarbiauja su tyrim\u0173 u\u017esakovais, mokslini\u0173 tyrim\u0173 institucijomis ir CRO, kad palengvint\u0173 Fabri ligos ir kit\u0173 ret\u0173 lig\u0173 klinikinius tyrimus.<\/p>\n<p class=\"x_MsoNormal\">M\u016bs\u0173 visapusi\u0161kos paramos paslaugos skirtos tam, kad klinikini\u0173 tyrim\u0173 patirtis pacientams b\u016bt\u0173 kuo sklandesn\u0117. Nuo \u0161vietimo ir konsultavimo iki kelion\u0117s ir logistikos koordinavimo - siekiame palengvinti na\u0161t\u0105, da\u017enai susijusi\u0105 su dalyvavimu moksliniuose tyrimuose. Be to, teikiame pirmenyb\u0119 pacient\u0173 saugai ir gerovei viso tyrimo proceso metu, u\u017etikrindami, kad dalyviai gaut\u0173 auk\u0161\u010diausio lygio prie\u017ei\u016br\u0105.<\/p>\n<p class=\"x_MsoNormal\"><strong><i>Kaip galite pad\u0117ti?<\/i><\/strong><\/p>\n<p class=\"x_MsoNormal\"><b>Dalyvaukite:<\/b>\u00a0Fabri ligos \u017einomumo m\u0117nesio metu ir po jo yra keletas b\u016bd\u0173, kaip \u012fsitraukti ir paremti Fabri liga sergan\u010dius asmenis:<\/p>\n<p class=\"x_MsoNormal\"><b>Didinti informuotum\u0105:<\/b>\u00a0Dalinkit\u0117s informacija apie Fabri lig\u0105 socialin\u0117je \u017einiasklaidoje, organizuokite informuotumo didinimo renginius arba dalyvaukite vietin\u0117je propagandin\u0117je veikloje.<\/p>\n<p class=\"x_MsoNormal\"><b>Remti mokslinius tyrimus:<\/b>\u00a0Apsvarstykite galimyb\u0119 aukoti organizacijoms, kurios finansuoja Fabri ligos mokslinius tyrimus, arba savanoriauti klinikiniuose tyrimuose, jei turite tam teis\u0119.<\/p>\n<p class=\"x_MsoNormal\"><b>Pasisakykite u\u017e prieig\u0105:<\/b>\u00a0Pasisakykite u\u017e politik\u0105, kuri u\u017etikrint\u0173 reta liga sergantiems asmenims galimyb\u0119 gauti \u012fperkam\u0105 gydym\u0105 ir paramos paslaugas.<\/p>\n<p class=\"x_MsoNormal\">Kartu galime pakeisti Fabri liga ir kitomis retomis ligomis sergan\u010di\u0173 pacient\u0173 gyvenim\u0105.<\/p>\n<p class=\"x_MsoNormal\">Fabri ligos \u017einomumo m\u0117nuo primena, kaip svarbu palaikyti retomis ligomis sergan\u010dius asmenis ir skatinti mokslinius tyrimus, kad b\u016bt\u0173 rasti veiksmingi gydymo b\u016bdai. Klinikoje \"Colpitts Clinical\" esame \u012fsipareigoj\u0119 suteikti daugiau galimybi\u0173 Fabri liga sergantiems pacientams, teikdami visapusi\u0161kas paramos paslaugas ir palengvindami prieig\u0105 prie naujovi\u0161k\u0173 gydymo b\u016bd\u0173 per klinikinius tyrimus. Bendradarbiaudami galime padaryti pa\u017eang\u0105 gerinant Fabri liga ir kitomis retomis ligomis sergan\u010di\u0173 \u017emoni\u0173 gyvenim\u0105. Prisijunkite prie m\u016bs\u0173 ir didinkite informuotum\u0105, remkite mokslinius tyrimus ir pasisakykite u\u017e tai, kad prie\u017ei\u016bra b\u016bt\u0173 prieinama. Kartu mes galime suma\u017einti atotr\u016bk\u012f ir suteikti vilties pacientams ir j\u0173 \u0161eimoms.<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>Skaitykite daugiau apie klinikinius tyrimus<\/strong><\/em><\/p>\n<p><a href=\"https:\/\/colpittsclinical.com\/lt\/how-travel-services-build-a-better-clinical-trial-travel-experience\/\">Kaip kelioni\u0173 paslaugos sukuria geresn\u0119 klinikini\u0173 tyrim\u0173 kelioni\u0173 patirt\u012f<\/a><\/p>\n<p><a href=\"https:\/\/colpittsclinical.com\/lt\/vital-role-of-clinical-trials-and-supportive-travel-coordination\/\">Svarbus klinikini\u0173 tyrim\u0173 ir pagalbini\u0173 kelioni\u0173 koordinavimo vaidmuo<\/a><\/p>\n<p><a href=\"https:\/\/colpittsclinical.com\/lt\/colpitts-clinical-making-the-impossible-possible\/\">Ne\u012fmanomus dalykus paversti \u012fmanomais<\/a><\/p>\n<p>Aplankykite mus\u00a0<a href=\"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/\">\"Facebook\"<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Bridging the Gap: Supporting Patients with Fabry Disease Through Clinical Trials April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide. At Colpitts Clinical, we recognize the importance of supporting patients living with rare diseases like Fabry and ensuring they have access to cutting-edge [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[6,30],"tags":[],"class_list":["post-5116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-trials","category-rare-diseases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical<\/title>\n<meta name=\"description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/colpittsclinical.com\/lt\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\" \/>\n<meta property=\"og:description\" content=\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/colpittsclinical.com\/lt\/supporting-patients-with-fabry-disease-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Colpitts Clinical\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-17T04:08:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-22T03:52:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"828\" \/>\n\t<meta property=\"og:image:height\" content=\"420\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"clinical\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"clinical\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minut\u0117s\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"author\":{\"name\":\"clinical\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\"},\"headline\":\"Supporting Patients with Fabry Disease in Clinical Trials\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"},\"wordCount\":542,\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"articleSection\":[\"Clinical Trials\",\"Rare Diseases\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\",\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"datePublished\":\"2024-04-17T04:08:03+00:00\",\"dateModified\":\"2024-04-22T03:52:52+00:00\",\"description\":\"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/fabry_disease.jpg?fit=828%2C420&ssl=1\",\"width\":828,\"height\":420,\"caption\":\"Supporting patients with Fabry disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/supporting-patients-with-fabry-disease-in-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/colpittsclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Supporting Patients with Fabry Disease in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"name\":\"Colpitts Clinical\",\"description\":\"patient-liaison\",\"publisher\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/colpittsclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#organization\",\"name\":\"Colpitts Clinical\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"contentUrl\":\"https:\\\/\\\/colpittsclinical.com\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/cc-logo-212-1.png\",\"width\":212,\"height\":48,\"caption\":\"Colpitts Clinical\"},\"image\":{\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ColpittsClinicalTrialTravel\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/colpittsclinical\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/colpittsclinical.com\\\/#\\\/schema\\\/person\\\/7f5c1f500aa2df676ac51a2c6236e2fd\",\"name\":\"clinical\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g\",\"caption\":\"clinical\"},\"url\":\"https:\\\/\\\/colpittsclinical.com\\\/lt\\\/author\\\/cclinical\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/colpittsclinical.com\/lt\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_locale":"lt_LT","og_type":"article","og_title":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","og_description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","og_url":"https:\/\/colpittsclinical.com\/lt\/supporting-patients-with-fabry-disease-in-clinical-trials\/","og_site_name":"Colpitts Clinical","article_publisher":"https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","article_published_time":"2024-04-17T04:08:03+00:00","article_modified_time":"2024-04-22T03:52:52+00:00","og_image":[{"width":828,"height":420,"url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg","type":"image\/jpeg"}],"author":"clinical","twitter_card":"summary_large_image","twitter_misc":{"Written by":"clinical","Est. reading time":"3 minut\u0117s"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"author":{"name":"clinical","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd"},"headline":"Supporting Patients with Fabry Disease in Clinical Trials","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","mainEntityOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"},"wordCount":542,"publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","articleSection":["Clinical Trials","Rare Diseases"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","url":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/","name":"Supporting Patients with Fabry Disease in Clinical Trials - Colpitts Clinical","isPartOf":{"@id":"https:\/\/colpittsclinical.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","datePublished":"2024-04-17T04:08:03+00:00","dateModified":"2024-04-22T03:52:52+00:00","description":"April is a month dedicated to raising awareness about Fabry Disease, a rare genetic disorder that affects thousands of individuals worldwide.","breadcrumb":{"@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#primaryimage","url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","contentUrl":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","width":828,"height":420,"caption":"Supporting patients with Fabry disease"},{"@type":"BreadcrumbList","@id":"https:\/\/colpittsclinical.com\/supporting-patients-with-fabry-disease-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/colpittsclinical.com\/"},{"@type":"ListItem","position":2,"name":"Supporting Patients with Fabry Disease in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/colpittsclinical.com\/#website","url":"https:\/\/colpittsclinical.com\/","name":"Colpitts Clinical","description":"paciento ir draugo ry\u0161ys","publisher":{"@id":"https:\/\/colpittsclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/colpittsclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/colpittsclinical.com\/#organization","name":"Colpitts Clinical","url":"https:\/\/colpittsclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","contentUrl":"https:\/\/colpittsclinical.com\/wp-content\/uploads\/2017\/10\/cc-logo-212-1.png","width":212,"height":48,"caption":"Colpitts Clinical"},"image":{"@id":"https:\/\/colpittsclinical.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ColpittsClinicalTrialTravel\/","https:\/\/www.linkedin.com\/company\/colpittsclinical\/"]},{"@type":"Person","@id":"https:\/\/colpittsclinical.com\/#\/schema\/person\/7f5c1f500aa2df676ac51a2c6236e2fd","name":"klinikinis","image":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b87dd30974d276d493a32a1592debd029f0e03dcf67fc5da941cf694874d67de?s=96&d=mm&r=g","caption":"clinical"},"url":"https:\/\/colpittsclinical.com\/lt\/author\/cclinical\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/colpittsclinical.com\/wp-content\/uploads\/2024\/04\/fabry_disease.jpg?fit=828%2C420&ssl=1","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/posts\/5116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/comments?post=5116"}],"version-history":[{"count":4,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/posts\/5116\/revisions"}],"predecessor-version":[{"id":5122,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/posts\/5116\/revisions\/5122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/media\/5132"}],"wp:attachment":[{"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/media?parent=5116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/categories?post=5116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colpittsclinical.com\/lt\/wp-json\/wp\/v2\/tags?post=5116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}